We are live on ! Find out more
VCYT icon

Veracyte

208 hedge funds and large institutions have $1.28B invested in Veracyte in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 77 increasing their positions, 65 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,859% more call options, than puts

Call options by funds: $5.15M | Put options by funds: $174K

106% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 16

18% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 65

8% more funds holding

Funds holding: 193208 (+15)

0.35% less ownership

Funds ownership: 108.39%108.04% (-0.35%)

16% less capital invested

Capital invested by funds: $1.52B → $1.28B (-$242M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
208
Holders Change
+15
Holders Change %
+7.77%
% of All Funds
3.58%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
33
Increased
77
Reduced
65
Closed
16
Calls
$5.15M
Puts
$174K
Net Calls
+$4.97M
Net Calls Change
+$1.93M
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
101
Deutsche Bank
Germany
$632K -$116K -5,140 -12%
MIM
102
MetLife Investment Management
New Jersey
$630K
Man Group
103
Man Group
United Kingdom
$587K +$795K +35,334 New
AIG
104
American International Group
New York
$565K +$10.8K +480 +1%
Stifel Financial
105
Stifel Financial
Missouri
$560K -$7.9K -351 -1%
Royal Bank of Canada
106
Royal Bank of Canada
Ontario, Canada
$558K -$233K -10,348 -23%
Bank Julius Baer & Co
107
Bank Julius Baer & Co
Switzerland
$535K -$435K -19,335 -38%
M&T Bank
108
M&T Bank
New York
$531K -$112K -4,966 -13%
PAM
109
Panagora Asset Management
Massachusetts
$528K
T. Rowe Price Associates
110
T. Rowe Price Associates
Maryland
$521K +$6.71K +298 +1%
Tudor Investment Corp
111
Tudor Investment Corp
Connecticut
$514K +$697K +30,966 New
CCIA
112
Campbell & Co Investment Adviser
Maryland
$498K +$675K +29,991 New
GAM
113
Gotham Asset Management
New York
$490K -$21.6K -960 -3%
First Trust Advisors
114
First Trust Advisors
Illinois
$480K +$366K +16,281 +129%
EGM
115
Engineers Gate Manager
New York
$476K +$285K +12,651 +79%
Manulife (Manufacturers Life Insurance)
116
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$470K -$12.5K -556 -2%
HF
117
HRT Financial
New York
$466K +$633K +28,125 New
CAM
118
ClariVest Asset Management
California
$462K +$135K +5,999 +28%
Janus Henderson Group
119
Janus Henderson Group
United Kingdom
$452K +$307K +13,658 +100%
State Board of Administration of Florida Retirement System
120
State Board of Administration of Florida Retirement System
Florida
$428K
GCM
121
Graham Capital Management
Connecticut
$418K +$567K +25,216 New
DekaBank Deutsche Girozentrale
122
DekaBank Deutsche Girozentrale
Germany
$395K
EFM
123
E Fund Management
China
$394K +$21.3K +946 +4%
Teacher Retirement System of Texas
124
Teacher Retirement System of Texas
Texas
$390K +$274K +12,163 +107%
BCI
125
Brinker Capital Investments
Pennsylvania
$353K +$50.1K +2,226 +12%

VCYT Hedge Fund Activity: Q3 2022 in Review

208 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2022, worth a combined $1.28B — down 16% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new VCYT positions and 16 closed out — a net gain of 17 holders — while 77 added to existing stakes and 65 trimmed.

The largest buyer was Dimensional Fund Advisors, adding an estimated $17.2M. The largest seller was Invesco, cutting an estimated $79.3M.

  • 208 institutional investors held Veracyte (VCYT) as of Q3 2022, up from 193 in Q2 2022.
  • Funds reported $1.28B of Veracyte stock for Q3 2022, down 16% quarter-over-quarter.
  • 33 funds opened new Veracyte positions in Q3 2022 and 16 closed out, a net change of +17 holders.
  • The largest Veracyte buyer in Q3 2022 was Dimensional Fund Advisors, an estimated $17.2M added.
  • The largest Veracyte seller in Q3 2022 was Invesco, an estimated $79.3M sold.

Based on aggregated 13F filings for Q3 2022.